Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58K Hold
22
﹤0.01% 293
2026
Q1
$2.6K Hold
22
﹤0.01% 258
2025
Q4
$2.77K Sell
22
-22
-50% -$2.87K ﹤0.01% 266
2025
Q3
$6.44K Hold
44
0.01% 187
2025
Q2
$6.86K Hold
44
0.01% 171
2025
Q1
$7.17K Sell
44
-22
-33% -$3.66K 0.01% 161
2024
Q4
$10.8K Sell
66
-23
-26% -$4.11K 0.01% 153
2024
Q3
$17.4K Hold
89
0.02% 142
2024
Q2
$15.4K Hold
89
0.02% 149
2024
Q1
$15.1K Hold
89
0.01% 141
2023
Q4
$17.6K Buy
+89
New +$15.8K 0.02% 141

Other funds holding ZTS

Fairman Group's ZTS Position: Q2 2026 in Review

Fairman Group held its Zoetis (ZTS) position steady in Q2 2026 at 22 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #293.

Fairman Group first reported a position in ZTS in Q4 2023 and has held it in 11 quarters since. The position peaked at $17.6K in Q4 2023. 1,433 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Fairman Group held 22 shares of Zoetis worth $1.58K as of Q2 2026.
  • Fairman Group left its Zoetis share count unchanged in Q2 2026.
  • Zoetis made up ﹤0.01% of Fairman Group's portfolio in Q2 2026, its #293 holding.
  • Fairman Group first reported a position in Zoetis in Q4 2023 and has held it in 11 quarters since.
  • Fairman Group's Zoetis position peaked at $17.6K in Q4 2023.
  • 1,433 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.